Newsdesk, June 24, 2025 - Changsha Morning Shine Co., Ltd a top rated Chinese biotechnology innovator proudly announced the expansion of its global footprint in the advanced peptide intermediate portfolio. The company specialises in semaglutide and tirzepatide fragments, along with Monodiverse Derivatives and Common Fragments. Headquartered in Changsha City, China, the company delivers strictly high-purity pharmaceutical raw materials & life science and diagnostic reagents at GMP-compliant scales to meet the growing research demands of global pharmaceutical manufacturers and R&D organisations.Also known as Morning Shine, the company comes with state-of-the-art instrumentation for its research. This includes items like 600 MHz NMR, LC-MS/MS, and HPLC systems, which makes sure of exceptional quality and consistency throughout the experiments. Its ISO 9001-certified operations integrate ELN/LIMS so that every last strand of data remains secured in closed loop along with rigorous quality control. The company’s technical platforms span chemical synthesis, analytical chemistry, biotechnology, and purification. It also supports more than a thousand partners worldwide with its special services like custom synthesis, impurity analysis, and CRO services.
About
Changsha Morning Shine Co., Ltd is a leading biotechnology company based in China, specialising in high-purity pharmaceutical intermediates, advanced chemical synthesis, and CRO services. With ISO-certified operations and cutting-edge analytical platforms, the company serves global biopharma clients with innovative, GMP-compliant solutions for research, development, and commercial-scale manufacturing.
Contact
Address - No.102, Building 15, No. 426, Guyuan Road, High-tech Development Zone, Changsha City, Hunan Province, China
Phone number - +86 189 7583 2125
Website - www.mspharmx.com
Email - luohuichao@csmspharm.com
###